Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda

• Main Authors: Mary K Grabowski, PhD (Author), Prof. Ronald H Gray, MD (Author), Fred Makumbi, PhD (Author), Joseph Kagaayi, MBChB (Author), Andrew D Redd, PhD (Author), Godfrey Kigozi, MBChB (Author), Steven J Reynolds, MD (Author), Fred Nalugoda, MHS (Author), Tom Lutalo, MS (Author), Prof. Maria J Wawer, MD (Author), Prof. David Serwadda, MD (Author), Prof. Thomas C Quinn, MD (Author), Aaron A R Tobian, MD (Author)
• Format: Book
• Published: Elsevier, 2015-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The injectable hormonal contraceptive depo-medroxyprogesterone acetate (DMPA) has been associated with increased risk of HIV acquisition, but findings are inconsistent. Whether DMPA increases the risk of other sexually transmitted viral infections is unknown. We assessed the association...